FindTrial
Sign In

A study to see if adding dexmedetomidine to the anesthetic used for a shoulder nerve block provides longer and better pain relief after shoulder surgery.

Efficacy of low dose dexmedetomidine as a perineural adjunct to ropivacaine for single shot interscalene brachial plexus block in arthroscopic shoulder surgery - A prospective randomized controlled study. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106032
Enrollment
70
Registered
2026-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring

Interventions

Intervention1: Interventional Group : Ropivacaine with Dexmedetomidine: Preoperatively, patients receive 0.2% ropivacaine along with dexmedetomidine 0.5mcg/kg in ultrasound guided single shot intersca

Sponsors

NAGIPOGU PRIYANKA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria : 1.Patients aged 18-60 years 2.Undergoing elective shoulder arthroscopic surgery under general anesthesia. 3. American Society of anesthesiologists(ASA) physical status, classification I or II, indicating those with no systemic disease or mild systemic disease. 4.Ability to provide informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1.History of allergy or hypersensitivity to dexmedetomidine. 2. Patients on antihypertensives such as methyldopa, clonidine, and other alpha2 agonists 3. Having BMI more than 30kg/m , peripheral neuropathy, coagulopathies, uncontrolled diabetes, liver and kidney dysfunctions 4. Participating in other clinical trials currently.

Design outcomes

Primary

MeasureTime frame
The primary objective is to measure the duration of analgesiaTimepoint: T1 Before giving Block (R/DR) T2 After giving Block(R/DR) T5 5 min after block T10 10 min after block T15 15 min after block T20 20 min after block T25 25 min after block T30 30 min after block T45 45 min after block T60 60 min after block T90 90 min after block TE END OF SURGERY TP1 1 hr post surgery TP2 2 hr post surgery TP3 3 hr post surgery TP4 4 hr post surgery TP6 6 hr post surgery TP8 8 hr post surgery TP10 10 hr post surgery TP12 12 hr post surgery TP24 24 hr post surgery—

Secondary

MeasureTime frame
The secondary objective: a)To assess VAS (Visual Analog Scale) pain score. b) To monitor total intraoperative fentanyl requirement and postoperative tramadol requirement. c) To assess patient satisfaction (Likert scale). d) To monitor hemodynamic variables and complications if any. Timepoint: T1 Before giving Block (R/DR) T2 After giving Block(R/DR) T5 5 min after block T10 10 min after block T15 15 min after block T20 20 min after block T25 25 min after block T30 30 min after block T45 45 min after block T60 60 min after block T90 90 min after block TE END OF SURGERY TP1 1 hr post surgery TP2 2 hr post surgery TP3 3 hr post surgery TP4 4 hr post surgery TP6 6 hr post surgery TP8 8 hr post surgery TP10 10 hr post surgery TP12 12 hr post surgery TP24 24 hr post surgery—

Countries

India

Contacts

Public ContactDr NAGIPOGU PRIYANKA

Nizams Institute of medical sciences

narmadapadhy1@gmail.com9392408465

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026